NMSG13 - Fludarabine
Official title: Fludarabine added to induction treatment in untreated multiple myeloma patients: A randomised, placebo controlled, double blind phase II trialTrial start year: 2005
Trial website
No website available
Design paper
No design paper published
Result paper
No result paper published
![Interim paper](http://ctu.dk/wp-content/uploads/2020/12/NMSG13_main2009_remade-01.png)
Interim paper
2009
Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial
Download full paper